Valley Brook Capital Group Inc. Has $3.59 Million Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Valley Brook Capital Group Inc. lessened its position in UnitedHealth Group Incorporated (NYSE:UNH) by 0.9% in the fourth quarter, HoldingsChannel.com reports. The fund owned 7,088 shares of the healthcare conglomerate’s stock after selling 61 shares during the period. UnitedHealth Group comprises about 2.7% of Valley Brook Capital Group Inc.’s portfolio, making the stock its 8th biggest holding. Valley Brook Capital Group Inc.’s holdings in UnitedHealth Group were worth $3,586,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also modified their holdings of the stock. Gladstone Institutional Advisory LLC boosted its holdings in shares of UnitedHealth Group by 1.3% during the 4th quarter. Gladstone Institutional Advisory LLC now owns 13,863 shares of the healthcare conglomerate’s stock worth $7,013,000 after buying an additional 175 shares during the period. Perissos Private Wealth Management LLC bought a new stake in shares of UnitedHealth Group during the 4th quarter worth about $259,000. Capital Advisors Inc. OK boosted its holdings in shares of UnitedHealth Group by 13.8% during the 4th quarter. Capital Advisors Inc. OK now owns 75,974 shares of the healthcare conglomerate’s stock worth $38,432,000 after buying an additional 9,197 shares during the period. Certuity LLC raised its stake in UnitedHealth Group by 24.1% in the 4th quarter. Certuity LLC now owns 2,825 shares of the healthcare conglomerate’s stock worth $1,429,000 after purchasing an additional 548 shares in the last quarter. Finally, Community Financial Services Group LLC raised its stake in UnitedHealth Group by 5.2% in the 4th quarter. Community Financial Services Group LLC now owns 12,937 shares of the healthcare conglomerate’s stock worth $6,544,000 after purchasing an additional 634 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Up 0.1 %

UNH opened at $533.99 on Wednesday. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The firm has a market capitalization of $491.42 billion, a price-to-earnings ratio of 34.45, a PEG ratio of 1.45 and a beta of 0.61. The company’s 50 day moving average price is $527.67 and its two-hundred day moving average price is $564.22.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. During the same period in the previous year, the firm posted $5.83 EPS. The company’s revenue for the quarter was up 6.8% compared to the same quarter last year. As a group, research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

Insider Activity

In other news, Director Timothy Patrick Flynn acquired 1,000 shares of UnitedHealth Group stock in a transaction dated Friday, January 17th. The shares were bought at an average cost of $511.57 per share, with a total value of $511,570.00. Following the purchase, the director now owns 4,500 shares in the company, valued at $2,302,065. This trade represents a 28.57 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at this hyperlink. Insiders own 0.33% of the company’s stock.

Analyst Ratings Changes

Several analysts have weighed in on the stock. Truist Financial dropped their price objective on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research note on Monday, January 6th. Morgan Stanley dropped their price objective on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a research note on Wednesday, October 16th. StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday, January 23rd. Deutsche Bank Aktiengesellschaft boosted their target price on shares of UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a research report on Tuesday, December 3rd. Finally, UBS Group dropped their target price on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday, October 16th. One analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Buy” and an average price target of $629.32.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.